Literature DB >> 22553745

A comparing study of quantitative staining techniques for retinal neovascularization in a mouse model of oxygen-induced retinopathy.

Xiao-Ling Liang1, Jie Li, Fang Chen, Xiao-Yan Ding, Xiu-Xia Yang, Liao-Xu Long.   

Abstract

AIM: To explore an efficient, practical and objective quantitative method to evaluate the retinal neovascularization in mouse model of oxygen induced retinopathy (OIR).
METHODS: Thirty C57BL/6J mice were explored in OIR model procedure. Eyes were removed for different staining methods including: (1) HE staining; (2) immunohistochemistry with Griffonia Simplicifolia Lectin(GSL); (3) Immunofluorescence with FITC labeled CD31 antibody; (4) Two-step immunofluorescence with purified-CD31 antibody; (5) FITC-Dextran perfusion combined with two-step purified-CD31immunofluorescence. Images of the retinal vasculature were analyzed by imaging software.
RESULTS: GSL immunohistochemistry could clearly demonstrate the deep and superficial capillary beds. FITC labeled CD31 Immunofluorescence was blurring with high fluorescence background which was hard to distinguish retinal neovascularization in some area. Excellent detail of neovascularization and preexistent retinal vessels was provided in two-step Purified-CD31 immunofluorescence group.
CONCLUSION: GSL immunohistochemistry can clearly demonstrate neovascularization tufts in deep and superficial capillary beds. Immunofluorescence of specific antigen CD31 on vascular endothelium can selectively label the neovascularization of mouse retina. When combined with computer analysis software, it is an effective and objective quantitative method to evaluate the retinal neovascularization in OIR mouse model.

Entities:  

Keywords:  CD31, hematoxylin-eosin staining; endothelial cell; immunofluorescence; immunohistochemistry; neovascularization; retinopathy of prematurity

Year:  2012        PMID: 22553745      PMCID: PMC3340848          DOI: 10.3980/j.issn.2222-3959.2012.01.01

Source DB:  PubMed          Journal:  Int J Ophthalmol        ISSN: 2222-3959            Impact factor:   1.779


  18 in total

1.  [Establishment of experimental angiogenic models with applications of quantitative digital image analysis].

Authors:  Jin-ling Jiang; Wei-ren Liu; Ying-yan Yu; Pei-hua Ni; Jian-lin Wu; Jun Ji; Jia-nian Zhang; Xue-hua Chen; Bing-ya Lu; Zheng-gang Zhu
Journal:  Zhonghua Bing Li Xue Za Zhi       Date:  2011-07

Review 2.  Animal models of choroidal and retinal neovascularization.

Authors:  Hans E Grossniklaus; Shin J Kang; Lennart Berglin
Journal:  Prog Retin Eye Res       Date:  2010-05-19       Impact factor: 21.198

Review 3.  Retinopathy of prematurity: understanding ischemic retinal vasculopathies at an extreme of life.

Authors:  Przemyslaw Sapieha; Jean-Sebastien Joyal; José Carlos Rivera; Elsa Kermorvant-Duchemin; Florian Sennlaub; Pierre Hardy; Pierre Lachapelle; Sylvain Chemtob
Journal:  J Clin Invest       Date:  2010-09-01       Impact factor: 14.808

Review 4.  Retinal and choroidal neovascularization.

Authors:  P A Campochiaro
Journal:  J Cell Physiol       Date:  2000-09       Impact factor: 6.384

5.  Attenuation of retinal vascular development and neovascularization in PECAM-1-deficient mice.

Authors:  Terri A Dimaio; Shoujian Wang; Qiong Huang; Elizabeth A Scheef; Christine M Sorenson; Nader Sheibani
Journal:  Dev Biol       Date:  2008-01-22       Impact factor: 3.582

6.  Normal vascular development in mice deficient in endothelial NO synthase: possible role of neuronal NO synthase.

Authors:  Mohamed Al-Shabrawey; Azza El-Remessy; Xiaolin Gu; Steven S Brooks; Mohamed S Hamed; Paul Huang; Ruth B Caldwell
Journal:  Mol Vis       Date:  2003-10-08       Impact factor: 2.367

7.  Prolyl hydroxylase inhibition during hyperoxia prevents oxygen-induced retinopathy.

Authors:  Jonathan E Sears; George Hoppe; Quteba Ebrahem; Bela Anand-Apte
Journal:  Proc Natl Acad Sci U S A       Date:  2008-12-04       Impact factor: 11.205

8.  Oxygen-induced retinopathy in the mouse.

Authors:  L E Smith; E Wesolowski; A McLellan; S K Kostyk; R D'Amato; R Sullivan; P A D'Amore
Journal:  Invest Ophthalmol Vis Sci       Date:  1994-01       Impact factor: 4.799

9.  In vivo immunostaining demonstrates macrophages associate with growing and regressing vessels.

Authors:  Jikui Shen; Bing Xie; Aling Dong; Mara Swaim; Sean F Hackett; Peter A Campochiaro
Journal:  Invest Ophthalmol Vis Sci       Date:  2007-09       Impact factor: 4.799

10.  VEGF guides angiogenic sprouting utilizing endothelial tip cell filopodia.

Authors:  Holger Gerhardt; Matthew Golding; Marcus Fruttiger; Christiana Ruhrberg; Andrea Lundkvist; Alexandra Abramsson; Michael Jeltsch; Christopher Mitchell; Kari Alitalo; David Shima; Christer Betsholtz
Journal:  J Cell Biol       Date:  2003-06-16       Impact factor: 10.539

View more
  3 in total

1.  Retro-orbital injection of FITC-dextran combined with isolectin B4 in assessing the retinal neovascularization defect.

Authors:  Jizhu Li; Yuqing Wu; Bingqian Liu; Ying Huang; Qingxiu Wu; Haichun Li; Sainan Xiao; Ying Lin; Tao Li
Journal:  BMC Ophthalmol       Date:  2021-05-11       Impact factor: 2.209

2.  Novel VEGF decoy receptor fusion protein conbercept targeting multiple VEGF isoforms provide remarkable anti-angiogenesis effect in vivo.

Authors:  Qin Wang; Tao Li; Zhigang Wu; Quan Wu; Xiao Ke; Delun Luo; Hui Wang
Journal:  PLoS One       Date:  2013-08-12       Impact factor: 3.240

3.  MiR-211 is essential for adult cone photoreceptor maintenance and visual function.

Authors:  Sara Barbato; Elena Marrocco; Daniela Intartaglia; Mariateresa Pizzo; Sabrina Asteriti; Federica Naso; Danila Falanga; Rajeshwari S Bhat; Nicola Meola; Annamaria Carissimo; Marianthi Karali; Haydn M Prosser; Lorenzo Cangiano; Enrico Maria Surace; Sandro Banfi; Ivan Conte
Journal:  Sci Rep       Date:  2017-12-05       Impact factor: 4.379

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.